Axceso Biopharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Axceso Biopharma General Information

Description

Operator of a biopharmaceutical company intended to treat all types of diseases. The company leverages technology and chemical synthesis to develop therapeutics for treating conditions such as sepsis, chemotherapy, Alzheimer's disease, and diabetes, and also develops a medical device for the treatment of neurodegenerative diseases, enabling healthcare professionals with tools and services to treat patients effectively.

Contact Information

Website
axcesobiopharma.com
Formerly Known As
Phytos
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 912, Building A, 282, Hakui-ro, Dongan-gu, Anyang-si
  • Gyeonggi-do, Geumgang Pentarium IT Tower
  • Anyang, Gyeonggi
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 912, Building A, 282, Hakui-ro, Dongan-gu, Anyang-si
  • Gyeonggi-do, Geumgang Pentarium IT Tower
  • Anyang, Gyeonggi
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axceso Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Generating Revenue
2. Later Stage VC (Series A) 01-Aug-2021 Completed Generating Revenue
1. Seed Round 05-Jul-2020 $2.49M $2.49M Completed Generating Revenue
To view Axceso Biopharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Axceso Biopharma Patents

  • 34

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Axceso Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026187205-A1 Heterobicyclic compound and pharmaceutical composition comprising same Pending 06-Mar-2025
EP-4624482-A1 Pyrimidopyrimidinone compound and pharmaceutical composition comprising same Pending 23-Nov-2022
WO-2024112083-A1 Pyrimidopyrimidinone compound and pharmaceutical composition comprising same Inactive 23-Nov-2022
WO-2022260305-A1 Medium composition for inducing differentiation of stem cells into vascular endothelial cells Inactive 10-Jun-2021
CA-3190461-A1 Pyrimido pyrimidinone compound and pharmaceutical composition comprising the same Pending 16-Sep-2020 C07D487/04
To view Axceso Biopharma’s complete patent history, request access »

Axceso Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axceso Biopharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shinhan Capital Venture Capital Minority
Timefolio Asset Management Hedge Fund Minority
ES Investor Venture Capital Minority
Korea Investment Partners Venture Capital Minority
To view Axceso Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Axceso Biopharma FAQs

  • When was Axceso Biopharma founded?

    Axceso Biopharma was founded in 2010.

  • Where is Axceso Biopharma headquartered?

    Axceso Biopharma is headquartered in Anyang, South Korea.

  • What is the size of Axceso Biopharma?

    Axceso Biopharma has 8 total employees.

  • What industry is Axceso Biopharma in?

    Axceso Biopharma’s primary industry is Drug Discovery.

  • Is Axceso Biopharma a private or public company?

    Axceso Biopharma is a Private company.

  • What is Axceso Biopharma’s current revenue?

    The current revenue for Axceso Biopharma is .

  • How much funding has Axceso Biopharma raised over time?

    Axceso Biopharma has raised $2.49M.

  • Who are Axceso Biopharma’s investors?

    Shinhan Capital, Timefolio Asset Management, ES Investor, and Korea Investment Partners have invested in Axceso Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process